PCVX
USDVaxcyte Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$35.130
Máximo
$35.390
Mínimo
$34.260
Volumen
1.06M
Fundamentos de la Empresa
Capitalización de Mercado
4.4B
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
2.50M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update
-- Company Reported Positive Topline Safety, Tolerability and Immunogenicity Data from Phase 2 Dose-Finding Study of VAX-24 in Healthy Infants; Balance of Data Expected by End of 2025 -- -- Initiated Second and Final
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
SAN CARLOS, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (NASDAQ:PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today
Cantor Fitzgerald Initiates Coverage On Vaxcyte with Overweight Rating
Cantor Fitzgerald analyst Carter Gould initiates coverage on Vaxcyte with a Overweight rating.
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.